Eva Andres-Mateos in

Eva Andres-Mateos

Login to view DISC.
Associate Vice President - Preclinical Development - Gene Therapy at Eli Lilly and Company
📍 Boston, Massachusetts, United States

Eva Andres-Mateos is the Associate Vice President of Preclinical Development in Gene Therapy at Eli Lilly and Company. A results-oriented leader, she specializes in pharmacology, bioanalytical development, and advancing regulatory strategies from discovery to the early clinical stage. She earned her Ph. D. from Universidad Autónoma de Madrid.

Eva is a passionate advocate for improving the diagnosis and treatment of rare diseases. She actively supports women in science and has highlighted their work in finding treatments for challenging disorders. She maintains strong ties to the Spanish scientific community through organizations like ECUSA (Españoles Científicos en USA).

During her postdoctoral work at Johns Hopkins, she won the prestigious Helen B. Taussig Research Award for her novel research on muscle atrophy using hibernating squirrels.

Read the full overview →
Experience
8 Years
Current Role
Associate Vice President - Preclinical Development - Gene Therapy
Job Level
Senior
Location
Boston, Massachusetts, United States
Personality Overview

How Eva shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Eva cares about

Gene Therapy
Her entire career, including her current VP role and work at Atsena and Akouos, is dedicated to advancing gene therapy, with a focus on novel AAV capsids.
Rare Disease Advocacy
She is an outspoken supporter of improving diagnosis and treatment for rare diseases, as highlighted in her posts for #RareDiseaseDay.
+4 more topics Login to view topics
Career

Work history

10-2024
Associate Vice President - Preclinical Development - Gene Therapy
Eli Lilly and Company
2-2023 - 10-2024
Vice President of Translational Research
Atsena Therapeutics
3-2022 - 2-2023
Senior Director of Translational Research
Atsena Therapeutics
1-2021 - 3-2022
Senior Director and Head of Translational Research
Akouos
1-2019 - 12-2020
Director of Translational Research
Akouos
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Doctor of Philosophy (Ph.D.)
Universidad Autónoma de Madrid
Master of Pharmacy (MPharm)
Universidad Complutense de Madrid
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Eli Lilly and Company Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Eva. Free, 10 seconds.